Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Identify index funds that offer best value for retirement by comparing costs, diversification, and potential returns, with practical fund picks.
27,007 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Travel demand is returning, but 2026 presents varied challenges for United Airlines. This guide breaks down the Unite...
AI-driven demand pushed Intel, AMD, Arm and other AI stocks higher today. Learn what drove the rally, what it means f...
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
SanDisk surged roughly 3,700% in a year, but a broad market pullback and profit-taking have funds trimming positions ...
What counts as the ultimate “stress test” for housing in 2026? This article breaks down signals, scenarios, and pract...
As robotaxi plans advance, Tesla stock faces a critical test. This article explains why tesla stock gets wall Street ...
Ethereum has fallen sharply from its peak, leaving investors asking whether this pullback creates a real buying oppor...
A broad ETF focused on exponential technologies is delivering solid returns while avoiding heavy bets on any single s...
A JPMorgan note argues that a U.S. crypto market structure bill could pass by June and act as a positive catalyst for...
Ripple reveals an AI-driven security upgrade for the XRP Ledger after a batch-transaction bug. The move aims to harde...
Global defense markets are shifting as the US, Russia, and China advance missile programs. This report examines inves...